Lavior Featured in USA Today: Changing the Future of Diabetic Wound Care
For millions of people living with diabetes, wound care is more than a matter of comfort—it’s a matter of health, safety, and quality of life. When a small wound or sore goes untreated, it can lead to serious complications and, in severe cases, amputation.
That’s why we’re proud to share that Lavior was recently featured in USA Today for our affordable, effective, and natural approach to diabetic wound care. The article, titled “The Affordable, Effective, and Game-Changing Wound Care for People With Diabetes,” highlights how Lavior’s botanical solutions are redefining the standard of care.
A Growing Need for Better Diabetic Wound Care
Every year, an estimated 160,000 Americans undergo limb amputation as a result of diabetic wounds. Behind that statistic are countless patients who struggle with poor circulation, inflammation, and slow-healing skin—issues that make even minor injuries dangerous.
Traditional wound care options often rely on harsh chemicals, steroids, or antibiotics that can irritate sensitive skin or be inaccessible for long-term use. The need for a safe, gentle, and effective alternative has never been greater.
The Lavior Difference
At Lavior, we believe in the healing power of nature supported by science. Our products are formulated with Inula viscosa AGS-RIED, a patented botanical extract developed through years of bioengineering research. This ingredient has been shown to reduce inflammation, support the body’s natural healing processes, and provide soothing relief without the side effects associated with traditional treatments.
“Our mission is to heal people,” said Anabelle Savion, Lavior’s Co-Founder and COO. “We want to provide patients with an affordable, accessible option that truly makes a difference.”
Backed by Clinical Evidence
The USA Today feature highlights a recent clinical study published in the Journal of Wound Care led by Dr. Imaze Marian Davis, Lavior’s Chief Medical Officer. The study compared Lavior’s botanical hydrogel to another leading wound gel in patients with diabetic foot wounds.
The results were significant:
-
Patients using Lavior’s hydrogel showed a greater reduction in wound surface area.
-
Participants also reported less pain during the healing process.
-
Both gels achieved similar closure times, but Lavior provided a more comfortable healing experience.
These findings reinforce what healthcare providers and patients have been saying for years—Lavior’s botanical technology delivers real, measurable results.
Empowering Patients to Heal Naturally
Beyond the science, Lavior’s mission is deeply personal. Our products are designed to help patients take control of their health, improve their quality of life, and prevent amputations whenever possible.
“Our goal is to reach every person living with diabetes who needs a safe, effective solution,” said Gilad Savion, CEO of Lavior Pharma Inc. “Do not agree to amputation. There is a solution.”
Lavior’s diabetic hydrogel wound dressing helps keep wounds moist, just like natural tissue, to support faster and healthier recovery. The product is FDA-registered, affordable, and available over the counter, making advanced wound care accessible to more people than ever before.
A New Standard in Diabetic Skin Health
With recognition from USA Today and growing clinical validation, Lavior is proud to lead the movement toward a more compassionate, natural, and science-backed approach to diabetic wound care.
We believe that healing should be both effective and gentle—and that everyone deserves access to solutions that truly work.
💚 Learn more about how Lavior is transforming diabetic wound care: https://www.usatoday.com/story/sponsor-story/lavior-fph/2025/09/26/the-affordable-effective-and-game-changing-wound-care-for-people-with-diabetes/85868298007/